Search results for "Lobular"

showing 10 items of 77 documents

Parallel bursts of recent and rapid radiation in the Mediterranean and Eritreo-Arabian biodiversity hotspots as revealed byGlobulariaandCampylanthus(…

2018

0106 biological sciences0301 basic medicineMediterranean climateEcologybiologyEcologybiology.organism_classification010603 evolutionary biology01 natural sciencesBiodiversity hotspot03 medical and health sciencesGlobularia030104 developmental biologyGeographyMolecular phylogeneticsVicariancePlantaginaceaeBiological dispersalCampylanthusEcology Evolution Behavior and SystematicsJournal of Biogeography
researchProduct

Chemical ecology meets conservation biological control: identifying plant volatiles as predictors of floral resource suitability for an egg parasitoi…

2016

Conservation biological control aims to enhance natural enemy populations in crop habitats, e.g. by providing flowering plants as food resources. Suitable flower species must enhance the survival and fecundity of natural enemies but in addition they also need to be highly attractive and thus frequently visited. To date, few examples exist that have considered both criteria. In this study, we tested the effects of the flowering plants alyssum (Lobularia maritima), buckwheat (Fagopyrum esculentum), French marigold (Tagetes patula) and sweet basil (Ocimum basilicum) on the fecundity and olfactory attractiveness of the egg parasitoid Trissolcus basalis, an important biological control agent of …

0106 biological sciencesbiologyEcosystem serviceBiological pest controlTrissolcus basaliOcimumbiology.organism_classification010603 evolutionary biology01 natural sciencesChemical ecology010602 entomologySettore AGR/11 - Entomologia Generale E ApplicataOlfactometerNezara viridulaBotanyCompanion plantAlyssumLobularia maritimaBuckwheatAgronomy and Crop ScienceEgg parasitoidFagopyrumChemosensory responseJournal of Pest Science
researchProduct

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.

2021

Primary triple-negative invasive lobular breast carcinomas (TN-ILCs), which do not express hormone receptors and HER2 at diagnosis, are rare and poorly known. In this study, we analyzed the largest TN-ILC series ever reported in the literature, in comparison to phenotypically similar breast tumor subtypes: triple-negative invasive ductal carcinoma (TN-IDC) and hormone receptor-positive invasive lobular carcinoma (HR + ILC). All primary TN-ILCs registered in our database between 2000 and 2018 (n = 38) were compared to tumors from control groups, matched by stage and Elston/Ellis grade, with regard to clinical, pathologic, and immunohistochemical characteristics. A comparative molecular analy…

0301 basic medicineOncologyAdultmedicine.medical_specialtyPathologyReceptor ErbB-2Lobular carcinomaDNA Mutational AnalysisTriple Negative Breast NeoplasmsArticlePathology and Forensic Medicine03 medical and health sciencesBasal (phylogenetics)Phosphatidylinositol 3-Kinases0302 clinical medicineBreast cancerInternal medicinemedicineCarcinomaHumansskin and connective tissue diseasesSurvival analysisAgedAged 80 and overbusiness.industryMiddle Agedmedicine.diseaseAndrogen receptorbody regionsCarcinoma Lobular030104 developmental biologyPleomorphism (cytology)Receptors EstrogenReceptors Androgen030220 oncology & carcinogenesisInvasive lobular carcinomaMutationFemalebusinessModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
researchProduct

Heat- and pH-induced BSA conformational changes, hydrogel formation and application as 3D cell scaffold

2016

Aggregation and gelation of globular proteins can be an advantage to generate new forms of nanoscale biomaterials based on the fibrillar architecture. Here, we report results obtained by exploiting the proteins' natural tendency to self-organize in 3D network, for the production of new material based on BSA for medical application. In particular, at five different pH values the conformational and structural changes of the BSA during all the steps of the thermal aggregation and gelation have been analyzed by FTIR spectroscopy. The macroscopic mechanical properties of these hydrogels have been obtained by rheological measurements. The microscopic structure of the gels have been studied by AFM…

0301 basic medicineScaffoldHot TemperatureNanostructureBSACell SurvivalProtein ConformationGlobular proteinBiophysics?-aggregatesBiocompatible Materials02 engineering and technologymacromolecular substancesMicroscopy Atomic ForceBiochemistryMice03 medical and health sciencesProtein structureRheologySpectroscopy Fourier Transform Infraredβ-aggregateAnimalsCell-scaffoldFourier transform infrared spectroscopyMolecular BiologyNanoscopic scalechemistry.chemical_classificationTissue ScaffoldsChemistrySerum Albumin BovineHydrogelsHydrogen-Ion Concentration021001 nanoscience & nanotechnologySettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)NanostructuresHydrogelCrystallography030104 developmental biologyMechanical spectraBiophysicChemical engineeringFTIRSelf-healing hydrogelsMicroscopy Electron ScanningCattleStress MechanicalRheology0210 nano-technology
researchProduct

Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

2021

Abstract Background The GAIN-2 trial was designed to identify a superior intense dose-dense (idd) strategy for high-risk patients with early breast cancer. Here, we report an interim analysis, at which the predefined futility boundary was crossed. Patients and methods GAIN-2 was an open-label, randomised, multicentre phase III trial. Two thousand eight hundred and eighty seven patients were randomised 1:1 between three courses each of idd epirubicin (E) 150 mg/m2, nab-paclitaxel (nP) 330 mg/m2 and cyclophosphamide (C) 2000 mg/m2 (iddEnPC) versus four cycles of leucocyte nadir-based tailored and dose-dense EC (dtEC) followed by four cycles of tailored and dose-dense docetaxel (dtD) (dtEC-dtD…

AdultCancer Researchmedicine.medical_specialtyTime FactorsAdolescentPaclitaxelCyclophosphamideDose-dense chemotherapymedicine.medical_treatmentBreast NeoplasmsDocetaxelRisk AssessmentDisease-Free SurvivalYoung AdultRisk FactorsAlbuminsGermanyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesAdverse effectCyclophosphamideAgedEpirubicinChemotherapybusiness.industryCarcinoma Ductal BreastCancerMiddle AgedInterim analysismedicine.diseaseNeoadjuvant TherapyCarcinoma LobularCarcinoma Intraductal NoninfiltratingOncologyDocetaxelChemotherapy AdjuvantFemalebusinessmedicine.drugEpirubicinEuropean Journal of Cancer
researchProduct

The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma

2016

The prognostic value of sentinel lymph node micrometastases in invasive breast cancer patients is still widely debated. Even if, in the absence of unequivocal guidelines, the axillary lynphadenectomy is not still performed in the routine clinical care of these patients.We have retrospectively analyzed 746 patients with operable invasive breast cancer and clinically negative axillary lymph nodes. These patients underwent conservative surgery or total mastectomy with sentinel lymph node biopsy. Patients with micrometastases in the sentinel lymph node treated with axillary dissection has been checked and the involvement of the remaining lymph nodes analyzed. Patients with micrometastases in th…

AdultNeoplasms Hormone-DependentBiopsy Fine-NeedleBreast carcinomaBreast NeoplasmsHumansRadionuclide ImagingTechnetium Tc 99m Aggregated AlbuminMastectomyAgedRetrospective StudiesAged 80 and overSentinel Lymph Node BiopsyCarcinoma Ductal BreastMicrometaseMiddle AgedPrognosisCombined Modality TherapyCarcinoma LobularNeoplasm MicrometastasisLymphatic MetastasisBreast carcinoma; Micrometases; Sentinel lymph node; SurgeryAxillaLymph Node ExcisionFemaleSurgeryNeoplasm Recurrence LocalRadiopharmaceuticalsSentinel lymph node
researchProduct

p95HER-2 Predicts Worse Outcome in Patients with HER-2-Positive Breast Cancer

2006

AbstractBackground: The HER-2 receptor undergoes a proteolytic cleavage generating an NH2-terminally truncated fragment, p95HER-2, that is membrane-associated and tyrosine-phosphorylated. We have reported that p95HER-2, but not the full-length receptor, p185HER-2, correlated with the extent of lymph node involvement in patients with breast cancer and its expression was significantly enhanced in nodal metastatic tissue. These facts suggested an important role for p95HER-2 either as a marker or cause of metastasis and poor outcome in breast cancer. In this work, we have studied the prognostic value of p95HER-2 in breast cancer.Methods: Primary breast tumor tissues (n = 483) were from surgical…

AdultOncologyCancer ResearchPathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsMetastasisBreast cancerRisk FactorsInternal medicineBiomarkers TumorTumor Cells CulturedmedicineCarcinomaHumansLymph nodeSurvival rateAgedAged 80 and overbusiness.industryCarcinoma Ductal BreastHazard ratioMiddle AgedPrognosismedicine.diseasePrimary tumorConfidence intervalSurvival RateCarcinoma Lobularmedicine.anatomical_structureReceptors EstrogenOncologyLymphatic MetastasisFemaleLymph NodesReceptors ProgesteronebusinessClinical Cancer Research
researchProduct

Autoantibodies in breast cancer: their use as an aid to early diagnosis

2007

There is increasing evidence that the immune system produces a humoral response to cancer-derived antigens. This study assessed the diagnostic potential of autoantibodies to multiple known tumour-associated proteins.Sera from normal controls (n = 94), primary breast cancer patients (n = 97) and patients with ductal carcinoma in situ (DCIS) (n = 40) were investigated for the presence of autoantibodies to p53, c-myc, HER2, NY-ESO-1, BRCA1, BRCA2 and MUC1 antigens by enzyme-linked immunosorbent assay.Reproducibly elevated levels of autoantibodies were seen in at least one of the six antigens in 64% of primary breast cancer patient sera and 45% of patients with DCIS at a specificity of 85%. No …

AdultOncologyPathologymedicine.medical_specialtyAntibodies NeoplasmBreast NeoplasmsEnzyme-Linked Immunosorbent Assaymedicine.disease_causeSensitivity and SpecificityAutoimmunityCohort StudiesBreast cancerAntigenAntigens NeoplasmInternal medicinemedicineHumansMammographyNeoplasm Metastasisskin and connective tissue diseasesLymph nodeAgedAutoantibodiesAged 80 and overmedicine.diagnostic_testbusiness.industryAutoantibodyReproducibility of ResultsCancerHematologyMiddle Agedmedicine.diseaseCarcinoma LobularCarcinoma Intraductal NoninfiltratingEarly Diagnosismedicine.anatomical_structureIncreased riskReceptors EstrogenOncologyCase-Control StudiesFemalebusinessAnnals of Oncology
researchProduct

Imunohistochemical Demonstration of Carcinoembryonic Antigen (CEA) in 120 Mammary Carcinomas and its Correlation with Tumor Type, Grading, Staging Pl…

1985

Antisera to CEA were used for the immunohistochemical localization and quantification of this antigen in 120 Bouin-fixed, paraffin embedded mammary carcinomas. These results were compared to tumor type, grading, staging, biochemical receptor status, cytosolic CEA-levels of the same tumors, and preoperative plasma CEA-levels. Mammary carcinomas were usually characterized by a low percentage of CEA-positive tumor cells: 50.9% of the cases contained more than 5% CEA-positive tumor cells and were therefore defined as being CEA-histopositive in this study. A relation could be shown between CEA-histopositivity and the histologic tumor type. The majority of invasive lobular carcinomas, tubular, an…

AdultPathologymedicine.medical_specialtyReceptor Statusendocrine system diseasesBreast NeoplasmsPathology and Forensic MedicineImmunoenzyme TechniquesCarcinoembryonic antigenAntigenAntigens NeoplasmmedicineCarcinomaHumansneoplasmsEstrogen Receptor StatusGrading (tumors)Agedbiologybusiness.industryCarcinomaCell BiologyMiddle Agedmedicine.diseasedigestive system diseasesCarcinoembryonic AntigenCarcinoma Intraductal NoninfiltratingReceptors EstrogenInvasive lobular carcinomabiology.proteinImmunohistochemistryFemalebusinessPathology - Research and Practice
researchProduct

The accuracy of sentinel lymph node biopsy in the treatment of multicentric invasive breast cancer using a subareolar injection of tracer.

2008

BACKGROUND: The aim of this study was to evaluate the feasibility and the accuracy of sentinel lymph node biopsy in multicentric breast cancer (MBC) performed by means of a subareolar (SA) injection of both 99Tc-labeled human albumin colloid and lymphazurin. METHODS: Between January 2002 and October 2007, 34 patients with MBC with clinically negative axilla underwent sentinel lymph node biopsy (SLNB) followed by total axillary node dissection (AD). Overall successful identification rate of SLN was 100%; there were no false negatives and overall accuracy rate was 100%. RESULTS: The mean number of sentinel lymph nodes (SLNs) identified was 1.8 +/- 0.88 (range = 1-4); the mean number of axilla…

Adultmedicine.medical_specialtyAxillary lymph nodesInjections IntradermalSentinel lymph nodeBreast NeoplasmsIsosulfan BlueSettore MED/08 - Anatomia PatologicaCohort StudiesBreast cancerPredictive Value of TestsBiopsymedicineRosaniline DyesHumansRadioactive TracersColoring AgentsTechnetium Tc 99m Aggregated AlbuminAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyCarcinoma Ductal BreastReproducibility of ResultsSentinel Lymph Node Biopsy Multicentric Invasive Breast CancerMiddle Agedmedicine.diseaseSurgeryAxillaCarcinoma LobularSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureSurgeryFemaleBreast diseaseRadiologyLymphRadiopharmaceuticalsbusiness
researchProduct